The Russian probiotics market is expected to grow at a compound annual growth rate of 5.58% over the forecast period to reach a market size of US$1,414.488 million in 2027, from US$966.956 million in 2020.
Historically, support to farmers was mostly provided by high-income countries, but in recent years, such support has also become widespread in several emerging countries, in some cases to support an objective of domestic self-sufficiency in certain products. This is the case in the Russian Federation, for instance, where the government sets production targets for several agricultural commodities, inclusive of but not limited to meat, among others, and provides various forms of financial support to farmers. Nevertheless, the meat import ban imposed by the Russian Federation until the end of 2019, combined with the depreciation of its currency, has resulted in increased domestic prices, which in turn will aid in stimulating the country’s meat production. By 2028, meat production in Russia is expected to reach 11218 ktcwe; meat consumption is expected to reach 11648 ktcwe; and fish and seafood production are estimated to attain levels of 5537 kt. [Source: OECD-FAO Agricultural Outlook 2019-2028]. To this extent, it should be noted that in early November 2019, the Russian Agricultural Ministry presented a new feed and feed additives development program, in which it was officially acknowledged that optimization of livestock production required the integration of modern feeding technologies, high-quality feed, and feed additives. This suggests that there is a proactive initiative from the Russian government that has the potential to expand the Russian probiotics market for animal feed use during the forecast period. Currently, Cellobacterinan Enzymatic Probiotic for Cattle has been brought about by a Russian company, BIOTROF, which claims to have microorganisms that produce bacterial cellulases and has been introduced into the feed industry.
Besides, animal feed applications there has been considerable interest in health and wellbeing among Russian consumers that is poised to catapult the Russian probiotics market to a new echelon during the forecast period.
Russia is currently, witnessing a surge in innovation in a variety of food and beverage segments because of a myriad of factors, such as the growing awareness of consumers about various health benefits that are attributed to newer sources of nutrition than the traditional ones. Furthermore, the rising health consciousness coupled with allergies that consumers have developed towards dairy and meat products has steered the players in the food and beverage sector to fortify their products with probiotics to enable the consumers to maintain pristine gut health while simultaneously savouring their favourite snack and or food preparation. Furthermore, the emergence of a current pandemic, such as the recent outbreak of COVID-19, which has affected individuals in most of Eurasia and resulted in fatalities, has prompted consumers to prioritise their immune systems more than ever before, incorporating all viable measures to strengthen them. This shift has put a lot of focus on probiotics in food as well.
Recent development and expansions
The COVID-19 pandemic has had a positive impact on the probiotics industry. Some probiotic products and ingredients are used to boost the immune system. Many market companies had invested significantly in the development of new probiotic products. The Covid-19 outbreak has boosted the growth of Russia's probiotic industry. COVID-19 infection is less likely and/or less severe when probiotics are used. This has resulted in increased demand and supply for probiotic products. Existing Russian companies are heavily investing in the research and development of probiotic products.
|Market Size Value in 2020||US$966.956 million|
|Market Size Value in 2027||US$1,414.488 million|
|Growth Rate||CAGR of 5.58% from 2020 to 2027|
|Forecast Unit (Value)||USD Million|
|Segments Covered||Application, End-User, Function, Type, And Form|
|Companies Covered||Danone, Hylak forte, Novartis (Lek d. d.), Bifodan A/S|
|Customization Scope||Free report customization with purchase|
Novartis (Lek d. d.)
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.